Episode Summary
Our latest podcast explores the case for IO in early-stage NSCLC in our once in a lifetime world – the current Australian context. We review the medical oncology and surgical perspective of the current evidence for clinical benefit and what we have available in Australia. As clinicians, we are trained to give our best treatment upfront, so patient discussion is important in an environment where we can only prescribe IO therapy once during the patient’s lung cancer disease.
Show Hosts
- Dr Deme Karikios, Medical Oncologist from Nepean Hospital and Co-Chair of the Oncology Drugs Working Group
- Dr Lauren Brown, Medical Oncologist and Research Fellow at Nepean, Blacktown & Westmead Hospitals
- Dr Stephen Barnett, Cardiothoracic Surgeon at the Austin Hospital, Peter MacCallum, Royal Melbourne and Western General Hospitals
Sponsors
This podcast episode is sponsored by BMS.
